A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men

Context: As an alternative approach, administration of phytotherapeutic agents in management of benign prostate hyperplasia (BPH), is rapidly growing each day. Different authors have indicated effectiveness of Viola odorata L. (Violaceae), Echium amoenum Fisch. & C.A.Mey. (Boraginaceae) and Phys...

Full description

Bibliographic Details
Main Authors: Fatemeh Beiraghdar, Behzad Einollahi, Alireza Ghadyani, Yunes Panahi, Abbas Hadjiakhoondi, Mahdi Vazirian, Ali Salarytabar, Behrad Darvishi
Format: Article
Language:English
Published: Taylor & Francis Group 2017-01-01
Series:Pharmaceutical Biology
Subjects:
Online Access:http://dx.doi.org/10.1080/13880209.2017.1328445
id doaj-19a6fd1af9134e728a383debc66d4ff0
record_format Article
spelling doaj-19a6fd1af9134e728a383debc66d4ff02020-11-25T03:27:17ZengTaylor & Francis GroupPharmaceutical Biology1388-02091744-51162017-01-015511800180510.1080/13880209.2017.13284451328445A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) menFatemeh Beiraghdar0Behzad Einollahi1Alireza Ghadyani2Yunes Panahi3Abbas Hadjiakhoondi4Mahdi Vazirian5Ali Salarytabar6Behrad Darvishi7Baghiatallah University of Medical SciencesBaghiatallah University of Medical SciencesBaghiatallah University of Medical SciencesBaghiatallah University of Medical SciencesTehran University of Medical SciencesTehran University of Medical SciencesBreast Cancer Research Center ACECRBreast Cancer Research Center ACECRContext: As an alternative approach, administration of phytotherapeutic agents in management of benign prostate hyperplasia (BPH), is rapidly growing each day. Different authors have indicated effectiveness of Viola odorata L. (Violaceae), Echium amoenum Fisch. & C.A.Mey. (Boraginaceae) and Physalis alkekengi L. (Solanaceae) in treatment of BPH. However, none have reported the beneficial outcomes of the mixture yet. Objective: This study evaluates the therapeutical effects of V. odorata, E. amoenum and P. alkekengi mixture on symptomatic BPH patients. Materials and methods: Eighty six symptomatic BPH patients with International Prostate Symptom Score (IPSS) of more than 13 and prostate volume of more than 30 cm3 were randomly allocated to receive a two-week course of placebo (control group) or 1 mL of mixed hydro-alcoholic solution of P. alkekengi, E. amoenum and V. odorata extracts (1.5, 1 and 1.5% respectively) (treatment group). Results: IPSS score of incomplete urination (42.3 ± 2.04%), frequency of urination (20.08 ± 1.02%), intermittency (40.78 ± 2.16%), urgency (60.91 ± 3.14%), weak stream (50.58 ± 2.14%), straining (55.67 ± 2.53%) and nocturia (40.14 ± 1.89%) in treatment group were significantly decreased after treatment compare to placebo receiving group. Furthermore, the prostate volume (16.92 ± 0.89%) and extant urine volume (28.12 ± 1.36%) also significantly decreased in treatment group compared to control group. No significant side effects or abnormalities in biochemical tests and urinalysis were observed throughout the study. Discussion and conclusions: Based on results, mentioned mixture is safe and effective in improving life quality of patients suffering from BPH.http://dx.doi.org/10.1080/13880209.2017.1328445ipss scorequality of lifeprostate volumeextant urine volume
collection DOAJ
language English
format Article
sources DOAJ
author Fatemeh Beiraghdar
Behzad Einollahi
Alireza Ghadyani
Yunes Panahi
Abbas Hadjiakhoondi
Mahdi Vazirian
Ali Salarytabar
Behrad Darvishi
spellingShingle Fatemeh Beiraghdar
Behzad Einollahi
Alireza Ghadyani
Yunes Panahi
Abbas Hadjiakhoondi
Mahdi Vazirian
Ali Salarytabar
Behrad Darvishi
A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men
Pharmaceutical Biology
ipss score
quality of life
prostate volume
extant urine volume
author_facet Fatemeh Beiraghdar
Behzad Einollahi
Alireza Ghadyani
Yunes Panahi
Abbas Hadjiakhoondi
Mahdi Vazirian
Ali Salarytabar
Behrad Darvishi
author_sort Fatemeh Beiraghdar
title A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men
title_short A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men
title_full A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men
title_fullStr A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men
title_full_unstemmed A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men
title_sort two-week, double-blind, placebo-controlled trial of viola odorata, echium amoenum and physalis alkekengi mixture in symptomatic benign prostate hyperplasia (bph) men
publisher Taylor & Francis Group
series Pharmaceutical Biology
issn 1388-0209
1744-5116
publishDate 2017-01-01
description Context: As an alternative approach, administration of phytotherapeutic agents in management of benign prostate hyperplasia (BPH), is rapidly growing each day. Different authors have indicated effectiveness of Viola odorata L. (Violaceae), Echium amoenum Fisch. & C.A.Mey. (Boraginaceae) and Physalis alkekengi L. (Solanaceae) in treatment of BPH. However, none have reported the beneficial outcomes of the mixture yet. Objective: This study evaluates the therapeutical effects of V. odorata, E. amoenum and P. alkekengi mixture on symptomatic BPH patients. Materials and methods: Eighty six symptomatic BPH patients with International Prostate Symptom Score (IPSS) of more than 13 and prostate volume of more than 30 cm3 were randomly allocated to receive a two-week course of placebo (control group) or 1 mL of mixed hydro-alcoholic solution of P. alkekengi, E. amoenum and V. odorata extracts (1.5, 1 and 1.5% respectively) (treatment group). Results: IPSS score of incomplete urination (42.3 ± 2.04%), frequency of urination (20.08 ± 1.02%), intermittency (40.78 ± 2.16%), urgency (60.91 ± 3.14%), weak stream (50.58 ± 2.14%), straining (55.67 ± 2.53%) and nocturia (40.14 ± 1.89%) in treatment group were significantly decreased after treatment compare to placebo receiving group. Furthermore, the prostate volume (16.92 ± 0.89%) and extant urine volume (28.12 ± 1.36%) also significantly decreased in treatment group compared to control group. No significant side effects or abnormalities in biochemical tests and urinalysis were observed throughout the study. Discussion and conclusions: Based on results, mentioned mixture is safe and effective in improving life quality of patients suffering from BPH.
topic ipss score
quality of life
prostate volume
extant urine volume
url http://dx.doi.org/10.1080/13880209.2017.1328445
work_keys_str_mv AT fatemehbeiraghdar atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT behzadeinollahi atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT alirezaghadyani atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT yunespanahi atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT abbashadjiakhoondi atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT mahdivazirian atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT alisalarytabar atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT behraddarvishi atwoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT fatemehbeiraghdar twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT behzadeinollahi twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT alirezaghadyani twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT yunespanahi twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT abbashadjiakhoondi twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT mahdivazirian twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT alisalarytabar twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
AT behraddarvishi twoweekdoubleblindplacebocontrolledtrialofviolaodorataechiumamoenumandphysalisalkekengimixtureinsymptomaticbenignprostatehyperplasiabphmen
_version_ 1724588556960137216